Company Description Zymeworks is a publicly listed (NASDAQ:ZYME) clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation, bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks\' suite of complementary therapeutic platforms and…